SCHEMBL19660435

SCHEMBL19660435

COc1cncc2c(C)cccc12

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.44
CYP1A2 P05177 1/20 0.44
ALDH1A1 P00352 2/20 0.39
ATP4A P20648 2/20 0.38
ATP4B P51164 2/20 0.38
IDO1 P14902 1/20 0.37
PDPK1 O15530 1/20 0.37
NQO2 P16083 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
CYP19A1 P11511 1/20 0.37
PDE10A Q9Y233 1/20 0.36
EP300 Q09472 1/20 0.36
KAT8 Q9H7Z6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21783630 0.79 IDO1 (0.53) CYP1A2ALDH1A1IDO1KDM4EHPGD
SCHEMBL21783631 0.78 ATP4A (0.38) CYP1A2ALDH1A1ATP4AATP4BIDO1
SCHEMBL8404557 0.77 CYP1A2 (0.62) CYP2A6CYP1A2ALDH1A1HPGD
SCHEMBL9005269 0.77 CYP2A6 (0.62) CYP2A6CYP1A2ALDH1A1IDO1NQO2
SCHEMBL21783690 0.77 APP (0.38) CYP1A2ALDH1A1KDM4EPDE10A
SCHEMBL21237268 0.77 CA2 (0.35) CYP1A2ALDH1A1IDO1KDM4EHPGD
SCHEMBL25836327 0.77 CYP2C9 (0.37) CYP1A2ALDH1A1KDM4EHPGDCYP19A1
SCHEMBL27264144 0.73 CYP1A2 (0.44) CYP2A6CYP1A2ALDH1A1ATP4AATP4B
SCHEMBL19660423 0.73 MAOA (0.46) CYP2A6CYP1A2ALDH1A1IDO1HPGD
SCHEMBL13765864 0.72 CYP1A2 (0.48) CYP2A6CYP1A2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464286-B1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH INC (US) 2021-08-18 EP disclosed
WO-2017205538-A1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH, INC. (US) 2017-11-30 WO disclosed